BF, H., KN, R., GC, E., & Jr, M. D. (2020). Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy. Case reports in oncology, 13(3), 1483. https://doi.org/10.1159/000512013
Chicago Style (17th ed.) CitationBF, Hearon, Redelman KN, Elhomsy GC, and Moore DF Jr. "Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy." Case Reports in Oncology 13, no. 3 (2020): 1483. https://doi.org/10.1159/000512013.
MLA (9th ed.) CitationBF, Hearon, et al. "Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy." Case Reports in Oncology, vol. 13, no. 3, 2020, p. 1483, https://doi.org/10.1159/000512013.
Warning: These citations may not always be 100% accurate.